Hematologic Scinnohub Pharmaceutical identifies new plasmin inhibitors Aug. 30, 2022 No Comments Scinnohub Pharmaceutical Co. Ltd. has presented plasmin inhibitors reported to be useful for the treatment of hemorrhage.Read More
SBIR grant supports STRM.BIO's development of EV technology as gene therapy delivery platform July 27, 2022 No Comments
Murine model shows fibrin alpha crosslinking impairment behind thromboembolism July 18, 2022 No Comments
RSS